Last updated: April 27, 2026
Who Supplies Phenylephrine Hydrochloride in 0.9% Sodium Chloride?
Which product forms exist in the market?
Phenylephrine hydrochloride in 0.9% sodium chloride is sold primarily as parenteral infusion solutions for clinical use, typically as:
- IV injection/infusion in 0.9% sodium chloride (normal saline)
- Supplied in sterile single-dose or multi-dose containers depending on country and brand
How is the supply chain structured for this combination?
Supply for phenylephrine hydrochloride in 0.9% sodium chloride typically comes through:
- Finished dose manufacturers (sterile compounding by the NDA/ANDA holder for approved strengths and container types)
- Contract manufacturers producing sterile solution under GMP for brand holders
- API suppliers providing phenylephrine HCl used to formulate the finished sterile product
Primary supplier archetypes you can underwrite
Because “phenylephrine hydrochloride in 0.9% sodium chloride” is a combination presentation (drug plus diluent in a sterile solution), commercial purchasing is usually executed at the finished pharmaceutical product level (NDC/ATC-coded), not as a bulk API plus saline kit.
In practice, your sourcing plan should separate two spend pools:
- Finished sterile product suppliers (most relevant for hospitals and distributors)
- API suppliers (relevant for manufacturing scale-up, reconstitution, or parallel sterile manufacturing)
Finished product: typical supplier list structure (what matters in sourcing)
When selecting suppliers for this specific combination, institutions and distributors evaluate:
- Strength (most commonly expressed as mg/mL or concentration per mL)
- Container (glass vial, plastic bag, prefilled syringe)
- Pack size (single unit vs bulk cases)
- Regulatory listing (approved local registrations, e.g., FDA-approved label in the US, national marketing authorization in the EU)
- Supply reliability (allocation history, lead times, sterile batch release performance)
No complete supplier roster can be produced from the provided input
A definitive list of named suppliers requires at least one of the following to map the exact marketed product entry:
- Target jurisdiction (US, EU, UK, Canada, etc.)
- Dosage strength and container type (e.g., mg/mL; vial size or bag volume)
- Brand/generic listing identifiers (e.g., NDC, MA number, ATC + strength + pack)
The request provides only the drug and diluent and does not include the market-identifying attributes needed to map to specific, verified suppliers and their registered presentations.
Key Takeaways
- Phenylephrine hydrochloride in 0.9% sodium chloride is supplied mainly as a sterile IV solution.
- Sourcing decisions hinge on exact concentration and container format, plus local regulatory listing.
- A named supplier list cannot be compiled accurately from the provided information alone.
FAQs
-
Is phenylephrine hydrochloride in 0.9% sodium chloride always sold as a premixed IV solution?
Yes, the common hospital supply format is a sterile premix solution, not saline-only dilution.
-
What selection criteria drive supplier qualification for this product?
Concentration, container type, sterility assurance, local regulatory listing, and batch-release performance.
-
Can hospitals buy phenylephrine HCl API and mix with saline instead?
Some settings do compounding under local rules, but standard procurement usually targets the finished sterile product.
-
Why does strength and container size matter for sourcing?
Supply availability, regulatory listing, and dosing workflow differ by concentration and presentation.
-
What’s the fastest way to identify suppliers that can fulfill orders?
Use the exact marketed product identifiers in the target jurisdiction (strength, container, pack size, and regulatory listing).
References
[1] FDA. “Drug Shortages.” U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-shortages (accessed 2026-04-28).
[2] EMA. “Human medicines: information on medicines.” European Medicines Agency. https://www.ema.europa.eu/en/medicines (accessed 2026-04-28).
[3] WHO. “ATC/DDD Index.” World Health Organization Collaborating Centre for Drug Statistics Methodology. https://www.whocc.no/atc_ddd_index/ (accessed 2026-04-28).
